Nalidixic Acid

   
Google
 
Web NewDrugInformation.com

Nalidixic Acid


Drug - Nalidixic Acid
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Nalidixic Acid
Multiple ingredients are in alphabetical order.

Strength - 250MG
The potency of the active ingredient(s), Nalidixic Acid. May repeat for multiple part products.

Applicant - MUTUAL PHARM
The firm name holding legal responsibility for Nalidixic Acid. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 070270
The FDA assigned number to Nalidixic Acid. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Nalidixic Acid. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 29, 1988
The date Nalidixic Acid was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Nalidixic Acid. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Nalidixic Acid is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mutual Pharmaceutical Co Inc
The full name of the firm holding legal responsibility for the new application of Nalidixic Acid.

Nalidixic Acid